Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment Rationale and Design for APPLE (WJOG11218L): A Multicenter, Open-Label, Randomized Phase 3 Study of Atezolizumab and Platinum/Pemetrexed With or Without Bevacizumab for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.
Shiraishi Y, Kishimoto J, Tanaka K, Sugawara S, Daga H, Hirano K, Azuma K, Hataji O, Hayashi H, Tachihara M, Mitsudomi T, Seto T, Nakagawa K, Yamamoto N, Okamoto I. Shiraishi Y, et al. Among authors: hataji o. Clin Lung Cancer. 2020 Sep;21(5):472-476. doi: 10.1016/j.cllc.2020.03.010. Epub 2020 Apr 10. Clin Lung Cancer. 2020. PMID: 32381420 Clinical Trial.
Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study.
Takayama K, Atagi S, Imamura F, Tanaka H, Minato K, Harada T, Katakami N, Yokoyama T, Yoshimori K, Takiguchi Y, Hataji O, Takeda Y, Aoe K, Kim YH, Yokota S, Tabeta H, Tomii K, Ohashi Y, Eguchi K, Watanabe K. Takayama K, et al. Among authors: hataji o. Support Care Cancer. 2016 Aug;24(8):3473-80. doi: 10.1007/s00520-016-3156-8. Epub 2016 Mar 22. Support Care Cancer. 2016. PMID: 27003901 Free PMC article.
"Pseudoprogression" of Pulmonary Pleomorphic Carcinoma during Nivolumab Therapy.
Ito K, Hataji O, Katsuta K, Kobayashi T, Gabazza EC, Yatabe Y, Taguchi O, Yamamoto N. Ito K, et al. Among authors: hataji o. J Thorac Oncol. 2016 Oct;11(10):e117-9. doi: 10.1016/j.jtho.2016.05.002. Epub 2016 May 14. J Thorac Oncol. 2016. PMID: 27189927 Free article. No abstract available.
Sequential Therapy with Crizotinib and Alectinib in ALK-Rearranged Non-Small Cell Lung Cancer-A Multicenter Retrospective Study.
Ito K, Hataji O, Kobayashi H, Fujiwara A, Yoshida M, D'Alessandro-Gabazza CN, Itani H, Tanigawa M, Ikeda T, Fujiwara K, Fujimoto H, Kobayashi T, Gabazza EC, Taguchi O, Yamamoto N. Ito K, et al. Among authors: hataji o. J Thorac Oncol. 2017 Feb;12(2):390-396. doi: 10.1016/j.jtho.2016.07.022. Epub 2016 Aug 4. J Thorac Oncol. 2017. PMID: 27498387 Free article.
Sequential Use of ALK Inhibitors: An Optional Approach.
Ito K, Hataji O, Fujimoto H, Kobayashi T, D'Alessandro-Gabazza CN, Gabazza EC. Ito K, et al. Among authors: hataji o. J Thorac Oncol. 2016 Dec;11(12):e153-e154. doi: 10.1016/j.jtho.2016.10.005. J Thorac Oncol. 2016. PMID: 27866638 Free article. No abstract available.
Utility of Liquid Biopsy by Improved PNA-LNA PCR Clamp Method for Detecting EGFR Mutation at Initial Diagnosis of Non-Small-Cell Lung Cancer: Observational Study of 190 Consecutive Cases in Clinical Practice.
Ito K, Suzuki Y, Saiki H, Sakaguchi T, Hayashi K, Nishii Y, Watanabe F, Hataji O. Ito K, et al. Among authors: hataji o. Clin Lung Cancer. 2018 Mar;19(2):181-190. doi: 10.1016/j.cllc.2017.10.017. Epub 2017 Oct 28. Clin Lung Cancer. 2018. PMID: 29174086
A Retrospective Comparison of the Clinical Efficacy of Gefitinib, Erlotinib, and Afatinib in Japanese Patients With Non-Small Cell Lung Cancer.
Fujiwara A, Yoshida M, Fujimoto H, Nakahara H, Ito K, Nishihama K, Yasuma T, Hataji O, Taguchi O, D'Alessandro-Gabazza CN, Gabazza EC, Kobayashi T. Fujiwara A, et al. Among authors: hataji o. Oncol Res. 2018 Aug 23;26(7):1031-1036. doi: 10.3727/096504018X15151523767752. Epub 2018 Jan 10. Oncol Res. 2018. PMID: 29321093 Free PMC article.
Efficacy of osimertinib in a patient with non-small cell lung cancer harboring epithelial growth factor receptor exon 19 deletion/T790M mutation, with poor performance status.
Nishii Y, Hataji O, Ito K, Watanabe F, Kobayashi T, D'Alessandro-Gabazza C, Toda M, Taguchi O, Yamamoto N, Gabazza EC. Nishii Y, et al. Among authors: hataji o. Mol Clin Oncol. 2018 Feb;8(2):246-249. doi: 10.3892/mco.2017.1522. Epub 2017 Nov 29. Mol Clin Oncol. 2018. PMID: 29399354 Free PMC article.
Comparable immunoreactivity rates of PD-L1 in archival and recent specimens from non-small cell lung cancer.
Nakamura Y, Kobayashi T, Nishii Y, Suzuki Y, Saiki H, Ito K, Watanabe F, Nishihama K, Yasuma T, D'Alessandro-Gabazza CN, Katsuta K, Fujimoto H, Gabazza EC, Taguchi O, Hataji O. Nakamura Y, et al. Among authors: hataji o. Thorac Cancer. 2018 Nov;9(11):1476-1482. doi: 10.1111/1759-7714.12861. Epub 2018 Sep 12. Thorac Cancer. 2018. PMID: 30209885 Free PMC article.
106 results